Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease

Bita Esmaeli; Amir Ahmadi; Rosa Tang; Jade Schiffman; Razelle Kurzrock

doi:10.1016/S0002-9394(01)01141-2

Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease

Bita Esmaeli, Amir Ahmadi, Rosa Tang, Jade Schiffman, Razelle Kurzrock

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Abstract

PURPOSE: To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha. METHODS: Interventional case report. RESULTS: The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy. CONCLUSION: Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.

Original language	English (US)
Pages (from-to)	945-947
Number of pages	3
Journal	American Journal of Ophthalmology
Volume	132
Issue number	6
DOIs	https://doi.org/10.1016/S0002-9394(01)01141-2
State	Published - 2001

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0002-9394(01)01141-2

Cite this

@article{6e382f40480e48618243ee63da076d6f,

title = "Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease",

abstract = "PURPOSE: To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha. METHODS: Interventional case report. RESULTS: The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy. CONCLUSION: Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.",

author = "Bita Esmaeli and Amir Ahmadi and Rosa Tang and Jade Schiffman and Razelle Kurzrock",

year = "2001",

doi = "10.1016/S0002-9394(01)01141-2",

language = "English (US)",

volume = "132",

pages = "945--947",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

publisher = "Elsevier USA",

number = "6",

}

TY - JOUR

T1 - Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease

AU - Esmaeli, Bita

AU - Ahmadi, Amir

AU - Tang, Rosa

AU - Schiffman, Jade

AU - Kurzrock, Razelle

PY - 2001

Y1 - 2001

N2 - PURPOSE: To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha. METHODS: Interventional case report. RESULTS: The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy. CONCLUSION: Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.

AB - PURPOSE: To describe a 55-year-old male with Erdheim-Chester disease with bilateral orbital infiltration and visual loss who was successfully treated with interferon-alpha. METHODS: Interventional case report. RESULTS: The patient was treated with interferon-alpha and had an improvement in his clinical signs, including his visual acuity, after 4 weeks of interferon therapy. CONCLUSION: Interferon-alpha can be effective in the treatment of orbital infiltration secondary to Erdheim-Chester disease.

UR - http://www.scopus.com/inward/record.url?scp=0035205734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035205734&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(01)01141-2

DO - 10.1016/S0002-9394(01)01141-2

M3 - Article

C2 - 11730673

AN - SCOPUS:0035205734

SN - 0002-9394

VL - 132

SP - 945

EP - 947

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

IS - 6

ER -

Interferon therapy for orbital infiltration secondary to Erdheim-Chester disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this